12-18282409-A-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001288772.2(PIK3C2G):​c.328A>G​(p.Ser110Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

PIK3C2G
NM_001288772.2 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.13

Publications

0 publications found
Variant links:
Genes affected
PIK3C2G (HGNC:8973): (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma) The protein encoded by this gene belongs to the phosphoinositide 3-kinase (PI3K) family. PI3-kinases play roles in signaling pathways involved in cell proliferation, oncogenic transformation, cell survival, cell migration, and intracellular protein trafficking. This protein contains a lipid kinase catalytic domain as well as a C-terminal C2 domain, a characteristic of class II PI3-kinases. C2 domains act as calcium-dependent phospholipid binding motifs that mediate translocation of proteins to membranes, and may also mediate protein-protein interactions. This gene may play a role in several diseases, including type II diabetes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
RERGL (HGNC:26213): (RERG like) Predicted to enable G protein activity and GTP binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.16017258).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIK3C2GNM_001288772.2 linkc.328A>G p.Ser110Gly missense_variant Exon 2 of 33 ENST00000538779.6 NP_001275701.1 O75747F5H369B7ZLY6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIK3C2GENST00000538779.6 linkc.328A>G p.Ser110Gly missense_variant Exon 2 of 33 5 NM_001288772.2 ENSP00000445381.1 F5H369

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 02, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.328A>G (p.S110G) alteration is located in exon 2 (coding exon 1) of the PIK3C2G gene. This alteration results from a A to G substitution at nucleotide position 328, causing the serine (S) at amino acid position 110 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.020
T;.;T;T
Eigen
Benign
-0.35
Eigen_PC
Benign
-0.24
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.73
T;T;T;.
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.16
T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.1
.;.;L;L
PhyloP100
3.1
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.90
N;N;N;N
REVEL
Benign
0.090
Sift
Benign
0.066
T;T;T;T
Sift4G
Benign
0.31
T;T;T;T
Polyphen
0.082, 0.049
.;B;B;B
Vest4
0.089
MutPred
0.30
Gain of catalytic residue at S110 (P = 9e-04);Gain of catalytic residue at S110 (P = 9e-04);Gain of catalytic residue at S110 (P = 9e-04);Gain of catalytic residue at S110 (P = 9e-04);
MVP
0.66
MPC
0.012
ClinPred
0.58
D
GERP RS
4.8
PromoterAI
-0.0078
Neutral
Varity_R
0.095
gMVP
0.14
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr12-18435343; API